Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Crude Oil Rises Over 3%; US Home Prices Increase In October

Author: Avi Kapoor | December 26, 2023 01:20pm

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday.

The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The S&P 500 also rose, gaining, 0.34% to 4,770.79.

Check This Out: Top 3 Tech And Telecom Stocks That Could Blast Off In December

 

Leading and Lagging Sectors

 

Energy shares jumped by 0.8% on Tuesday.

In trading on Tuesday, health care shares fell by 0.1%.

 

Top Headline

 

The S&P CoreLogic Case-Shiller 20-city home price index rose by 4.9% year-over-year in October, recording the largest surge since Nov. 2022.

 

Equities Trading UP

 

Gracell Biotechnologies Inc. (NASDAQ:GRCL) shares shot up 59% to $9.88. AstraZeneca Plc (NASDAQ:AZN) agreed to acquire Gracell Biotechnologies, further strengthening AstraZeneca's cell therapy portfolio.

Shares of Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) got a boost, surging 93% to $2.31 after the company announced 95% accuracy results for HYLA blood sensor.

Stratasys Ltd. (NASDAQ:SSYS) shares were also up, gaining 11% to $14.51 after the company confirmed that it received a preliminary proposal from Nano Dimension to purchase all of its outstanding shares at $16.50 per share in cash.

 

Equities Trading DOWN

 

Adit EdTech Acquisition Corp. (NASDAQ:ADEX) shares dropped 18% to $4.1001. Adit EdTech Acquisition announced intention to voluntarily de-list from NYSE American.

Shares of Milestone Pharmaceuticals Inc. (NASDAQ:MIST) were down 34% to $1.9050 after the company announced that it received a Refusal to File letter from the FDA for the New Drug Application for self-administered etripamil nasal spray for the treatment of paroxysmal supraventricular tachycardia.

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) was down, falling 12% to $0.5281. Oncternal Therapeutics updated the status of its Phase 1/2 study of ONCT-808, a ROR1-targeting autologous CAR T, in patients with relapsed or refractory aggressive B-cell lymphoma.

Also Check This Out: Beat Inflation With These 3 High-Yielding Dividend Stocks In Energy Sector From Wall Street's Most Accurate Analysts

 

Commodities

 

In commodity news, oil traded up 3.3% to $76.02 while gold traded up 0.1% at $2,070.10.

Silver traded down 0.3% to $24.495 on Tuesday while copper rose 0.4% to $3.9190.

 

Asia Pacific Markets

 

Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 gaining 0.16%, and China’s Shanghai Composite Index falling 0.68%. India’s S&P BSE Sensex, meanwhile, rose 0.32%.

India's current account deficit shrank to $8.3 billion in the July-September quarter from $30.9 billion in the year-ago quarter. Japan’s unemployment rate came in unchanged at 2.5% in November.

 

Economics

 

The Chicago Fed National Activity Index increased to +0.03 in November, versus a revised reading of -0.66 in the prior month.

The S&P CoreLogic Case-Shiller 20-city home price index rose by 4.9% year-over-year in October, recording the largest surge since Nov. 2022.

The FHFA house price index rose by 0.3% from the prior month in October.

Now Read This: How To Earn $500 A Month From Nike Stock Following Quarterly Report

Posted In: ADEX AZN GRCL IINN MIST ONCT SSYS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist